AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne

Go back to AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne
Alabama Power Co. 5.875% Sr. Notes Series 2007B (NASDAQ: ALM) Delayed: 18.66 -0.15 (0.8%)
Previous Close $18.81    52 Week High $27.10 
Open $19.12    52 Week Low $24.10 
Day High $19.32    P/E N/A 
Day Low $18.65    EPS $0.00 
Volume 3,464,757       

Alabama Power Co. 5.875% Sr. Notes Series 2007B (NASDAQ: ALM) Delayed: 18.66 -0.15 (0.8%)
Previous Close $18.81    52 Week High $27.10 
Open $19.12    52 Week Low $24.10 
Day High $19.32    P/E N/A 
Day Low $18.65    EPS $0.00 
Volume 3,464,757